Straits Times Index
3,133.38 +26.29 (+0.85%) Nikkei
26,992.21 +776.42 (+2.96%) Hang Seng
17,079.51 -143.32 (-0.83%) FTSE 100
7,000.34 +91.58 (+1.33%) BTC-USD
19,913.29 +695.90 (+3.62%) CMC Crypto 200
452.60 +17.24 (+3.96%)
Marpai, Inc. (MRAI)
After hours:
| Previous close | 1.0400 |
| Open | 1.0658 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 2900 |
| Day's range | 1.0300 - 1.0658 |
| 52-week range | 0.6930 - 6.3100 |
| Volume | |
| Avg. volume | 184,804 |
| Market cap | 21.717M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.3950 |
| Earnings date | 11 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.50 |
- Business Wire
Marpai, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®
TAMPA, Fla., January 07, 2022--Marpai, Inc. (NASDAQ: MRAI), a deep learning technology company transforming third party administration in the self-funded health insurance market, today announced that an interview with CEO Edmundo Gonzalez will air on The RedChip Money Report® on Bloomberg TV on Saturday, Jan. 8 at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the United States.
- Business Wire
Marpai, Inc. Insiders Buy $1.1 Million of Common Stock
NEW YORK, December 20, 2021--Marpai, Inc. ("Marpai" or the "Company") (NASDAQ: MRAI), a deep learning technology company transforming third party administration (TPA) in the self-funded health insurance market, today announced the Company’s management and directors purchased $1.1 million of Marpai common stock.
- Business Wire
Marpai, Inc. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option
TAMPA, Fla., October 29, 2021--Marpai, Inc. (the "Company") (Nasdaq: MRAI), a deep learning technology company transforming third party administration in the healthcare self-funded market, today announced the closing of its initial public offering of 7,187,500 shares of its common stock at a public offering price of $4.00 per share, including 937,500 shares sold upon full exercise of the underwriters’ over-allotment option, for gross proceeds of $28.75 million, before deducting underwriting disc
